Refractory schizophrenia: A neglected clinical problem [2]

Revista Brasileira de Psiquiatria

Volumn 29, Issue 3, 2007, Pages 292-293

  Borgio, João Guilherme Fiorani ^a   Bressan, Rodrigo A ^a   Neto, Jair Borges Barbosa ^a   Daltio, Claudiane S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADOLESCENT; ADULT; ALCOHOL ABUSE; BRAZIL; COMORBIDITY; DEPRESSION; DRUG ABUSE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; OUTPATIENT; PATIENT COMPLIANCE; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCREENING TEST; TREATMENT OUTCOME; OUTPATIENT DEPARTMENT; HEART ARRHYTHMIA; HOSPITALIZATION; NEUTROPENIA; SCREENING; SEIZURE;

AMBULATORY CARE FACILITIES; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; SCHIZOPHRENIA;

EID: 34748920246     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462007000300019     Document Type: Letter

References (5)

1. Rosa MA, Marcolin MA, Elkis H. Avaliação dos fatores de aderência ao tratamento medicamentoso entre pacientes brasileiros com esquizofrenia. Rev Bras Psiquiatr. 2005;27(3):178-84.
2. Bressan RA, Pilowsky LS. Treatment Resistant Schizophrenia - improving social and daily function. London, UK: Harcourt Health Communication; 2000.
3. Kenneth O, Jobson MD. The International Psychopharmacology Algorithm Project (IPAP) - schizophrenia algorithm, schizophrenia algorithm nodes. (cited 27 mar 2006) Available at: http://www.ipap.org.
4. Bressan RA, Erlandsson K, Stone JM, Mulligan RS, Krystal JH, Ell PJ, Pilowsky LS. Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo. Biol Psychiatry. 2005;58(1):41-6.
5. Brunstein MG, Ghisolfi ES, Ramos FL, Lara DR. A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia. J Clin Psychiatry. 2005;66(2):213-9.